Bellerophon Therapeutics, Inc.·4

Sep 27, 8:16 AM ET

Tenenbaum Fabian 4

4 · Bellerophon Therapeutics, Inc. · Filed Sep 27, 2018

Insider Transaction Report

Form 4
Period: 2018-09-25
Tenenbaum Fabian
Chief Executive Officer
Transactions
  • Award

    Common Stock

    2018-09-25+224,299479,282 total

Documents

1 file
  • 4
    wf-form4_153805057850244.xmlPrimary

    FORM 4